# Filing Detail

Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0000950170-25-051358
Filing Date
2025-04-07
Accepted
2025-04-07 07:50:42
Documents
19

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRER14A | amrn-20250406.htm iXBRL | PRER14A | 2144387
2 | GRAPHIC | img154157136_0.jpg | GRAPHIC | 7999
3 | GRAPHIC | img154157136_1.jpg | GRAPHIC | 105009
4 | GRAPHIC | img154157136_2.jpg | GRAPHIC | 107803
5 | GRAPHIC | img154157136_3.jpg | GRAPHIC | 89407
| Complete submission text file | 0000950170-25-051358.txt |  | 4471803

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | amrn-20250406.xsd | EX-101.SCH | 41071
22 | EXTRACTED XBRL INSTANCE DOCUMENT | amrn-20250406_htm.xml | XML | 535515

Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: PRER14A | Act: 34 | File No.: 000-21392 | Film No.: 25816379
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)